Ana Catarina Sousa

Ms. Ana Catarina Sousa

Departamento de Clínicas Veterinárias, ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Bruna LopesBruna Lopes
Bruna Lopes
PSPatrícia Sousa
Patrícia Sousa
Rui AlvitesRui Alvites
Rui Alvites
MBMariana Esteves Vieira Branquinho
Mariana Esteves Vieira Branquinho
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
Ana Colette MaurícioAna Colette Maurício
Ana Colette Maurício
Peripheral nerve injuries (PNI) can have several etiologies, such as trauma and iatrogenic interventions, that can lead to the loss of structure and/or function impairment. These changes can cause partial or complete loss of motor and sensory functions, physical disability, and neuropathic pain, which in turn can affect the quality of life. This review aims to revisit the concepts associated with the PNI and the anatomy of the peripheral nerve is detailed to explain the different types of injury. Then, some of the available therapeutic strategies are explained, including surgical methods, pharmacological therapies, and the use of cell-based therapies alone or in combination with biomaterials in the form of tube guides. Nevertheless, even with the various available treatments, it is difficult to achieve a perfect outcome with complete functional recovery. This review aims to enhance the importance of new therapies, especially in severe lesions, to overcome limitations and achieve better outcomes. The urge for new approaches and the understanding of the different methods to evaluate nerve regeneration is fundamental from a One Health perspective. In vitro models followed by in vivo models are very important to be able to translate the achievements to human medicine.

Verified
Journal Article
Open access
PDF file
SBSara Isabel da Silva Biscaia
Sara Isabel da Silva Biscaia
MBMariana Esteves Vieira Branquinho
Mariana Esteves Vieira Branquinho
Rui AlvitesRui Alvites
Rui Alvites
RFRita Fonseca
Rita Fonseca
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
Nuno AlvesNuno Alves
Nuno Alves
Bone tissue engineering has been developed in the past decades, with the engineering of bone substitutes on the vanguard of this regenerative approach. Polycaprolactone-based scaffolds are fairly applied for bone regeneration, and several composites have been incorporated so as to improve the scaffolds’ mechanical properties and tissue in-growth. In this study, hydroxyapatite is incorporated on polycaprolactone-based scaffolds at two different proportions, 80:20 and 60:40. Scaffolds are produced with two different blending methods, solvent casting and melt blending. The prepared composites are 3D printed through an extrusion-based technique and further investigated with regard to their chemical, thermal, morphological, and mechanical characteristics. In vitro cytocompatibility and osteogenic differentiation was also assessed with human dental pulp stem/stromal cells. The results show the melt-blending-derived scaffolds to present more promising mechanical properties, along with the incorporation of hydroxyapatite. The latter is also related to an increase in osteogenic activity and promotion. Overall, this study suggests polycaprolactone/hydroxyapatite scaffolds to be promising candidates for bone tissue engineering, particularly when produced by the MB method.

22 March 2021 in Biology
Verified
Journal Article
Open access
PDF file
Rui AlvitesRui Alvites
Rui Alvites
MBMariana Esteves Vieira Branquinho
Mariana Esteves Vieira Branquinho
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
Bruna LopesBruna Lopes
Bruna Lopes
PSPatrícia Sousa
Patrícia Sousa
Ana Colette MaurícioAna Colette Maurício
Ana Colette Maurício
Medical and translational scientific research requires the use of animal models as an initial approach to the study of new therapies and treatments, but when the objective is an exploration of translational potentialities, classical models fail to adequately mimic problems in humans. Among the larger animal models that have been explored more intensely in recent decades, small ruminants, namely sheep and goats, have emerged as excellent options. The main advantages associated to the use of these animals in research works are related to their anatomy and dimensions, larger than conventional laboratory animals, but very similar to those of humans in most physiological systems, in addition to their low maintenance and feeding costs, tendency to be docile, long life expectancies and few ethical complications raised in society. The most obvious disadvantages are the significant differences in some systems such as the gastrointestinal, and the reduced amount of data that limits the comparison between works and the validation of the characterization essays. Despite everything, recently these species have been increasingly used as animal models for diseases in different systems, and the results obtained open doors for their more frequent and advantageous use in the future. The purpose of this review is to summarize the general principles related to the use of small ruminants as animal models, with a focus on regenerative medicine, to group the most relevant works and results published recently and to highlight the potentials for the near future in medical research.

25 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
PSPatrícia Sousa
Patrícia Sousa
Bruna LopesBruna Lopes
Bruna Lopes
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
AMAlícia De Sousa Moreira
Alícia De Sousa Moreira
ACAndré Coelho
André Coelho
Ana Colette MaurícioAna Colette Maurício
Ana Colette Maurício
Exosomes have shown promising potential as a therapeutic approach for wound healing. Nevertheless, the translation from experimental studies to commercially available treatments is still lacking. To assess the current state of research in this field, a systematic review was performed involving studies conducted and published over the past five years. A PubMed search was performed for English-language, full-text available papers published from 2018 to June 2023, focusing on exosomes derived from mammalian sources and their application in wound healing, particularly those involving in vivo assays. Out of 531 results, 148 papers were selected for analysis. The findings revealed that exosome-based treatments improve wound healing by increasing angiogenesis, reepithelization, collagen deposition, and decreasing scar formation. Furthermore, there was significant variability in terms of cell sources and types, biomaterials, and administration routes under investigation, indicating the need for further research in this field. Additionally, a comparative examination encompassing diverse cellular origins, types, administration pathways, or biomaterials is imperative. Furthermore, the predominance of rodent-based animal models raises concerns, as there have been limited advancements towards more complex in vivo models and scale-up assays. These constraints underscore the substantial efforts that remain necessary before attaining commercially viable and extensively applicable therapeutic approaches using exosomes.

Verified
Journal Article
Open access
PDF file
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
Rui AlvitesRui Alvites
Rui Alvites
Bruna LopesBruna Lopes
Bruna Lopes
PSPatrícia Sousa
Patrícia Sousa
AMAlícia De Sousa Moreira
Alícia De Sousa Moreira
Ana Colette MaurícioAna Colette Maurício
Ana Colette Maurício
The application of three-dimensional (3D) printing/bioprinting technologies and cell therapies has garnered significant attention due to their potential in the field of regenerative medicine. This paper aims to provide a comprehensive overview of 3D printing/bioprinting technology and cell therapies, highlighting their results in diverse medical applications, while also discussing the capabilities and limitations of their combined use. The synergistic combination of 3D printing and cellular therapies has been recognised as a promising and innovative approach, and it is expected that these technologies will progressively assume a crucial role in the treatment of various diseases and conditions in the foreseeable future. This review concludes with a forward-looking perspective on the future impact of these technologies, highlighting their potential to revolutionize regenerative medicine through enhanced tissue repair and organ replacement strategies.

22 December 2018 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
JCJ M Campos
J M Campos
Ana Catarina SousaAna Catarina Sousa
Ana Catarina Sousa
ACA R Caseiro
A R Caseiro
SPSilvia Santos Pedrosa
Silvia Santos Pedrosa
PPP O Pinto
P O Pinto
Ana Colette MaurícioAna Colette Maurício
Ana Colette Maurício
Development of synthetic bone substitutes has arisen as a major research interest in the need to find an alternative to autologous bone grafts. Using an ovine model, the present pre-clinical study presents a synthetic bone graft (Bonelike®) in combination with a cellular system as an alternative for the regeneration of non-critical defects. The association of biomaterials and cell-based therapies is a promising strategy for bone tissue engineering. Mesenchymal stem cells (MSCs) from human dental pulp have demonstrated both in vitro and in vivo to interact with diverse biomaterial systems and promote mineral deposition, aiming at the reconstruction of osseous defects. Moreover, these cells can be found and isolated from many species. Non-critical bone defects were treated with Bonelike® with or without MSCs obtained from the human dental pulp. Results showed that Bonelike® and MSCs treated defects showed improved bone regeneration compared with the defects treated with Bonelike® alone. Also, it was observed that the biomaterial matrix was reabsorbed and gradually replaced by new bone during the healing process. We therefore propose this combination as an efficient binomial strategy that promotes bone growth and vascularization in non-critical bone defects.